Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valeo Pharma Inc T.VPH.DB


Primary Symbol: T.VPH Alternate Symbol(s):  VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

Recent & Breaking News (TSX:VPH)

Valeo Pharma Obtains Public Reimbursement for Redesca(TM) and Redesca Hp(TM) in Quebec

PR Newswire November 15, 2021

Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® and Atectura® Breezhaler® In Alberta

PR Newswire November 3, 2021

Valeo Pharma Obtains Listings for Redesca in 700 Hospitals and Healthcare Facilities Across Canada

PR Newswire October 13, 2021

/C O R R E C T I O N from Source -- Valeo Pharma inc./

PR Newswire October 13, 2021

Valeo Pharma Completes Negotiations with Pan-Canadian Pharmaceutical Alliance for Enerzair® Breezhaler® and Atectura® Breezhaler®

PR Newswire October 5, 2021

Valeo Pharma Announces Record Revenues and Gross Margins for its Third Quarter 2021

PR Newswire September 22, 2021

Valeo Pharma To Report Third Quarter 2021 Results and Hold Investors Conference Call / Webcast

PR Newswire September 16, 2021

Valeo Pharma Reports on Launch of New Corporate Structure

PR Newswire August 16, 2021

Valeo Pharma Announces Additional Provincial Reimbursement Coverage for Redesca(TM) and Redesca HP(TM)

PR Newswire July 13, 2021

Valeo Pharma Reports its Second Quarter 2021 Results and Highlights

PR Newswire June 29, 2021

Valeo Pharma Closes $11.5 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

PR Newswire June 29, 2021

Valeo Pharma to Report Second Quarter 2021 Results and Hold Investors Conference Call / Webcast

Canada NewsWire June 23, 2021

Valeo Pharma Announces Commercial Launch of Enerzair® Breezhaler® and Atectura® Breezhaler®

PR Newswire June 22, 2021

IIROC Trade Resumption - VPH

Canada NewsWire June 9, 2021

Valeo Pharma Announces $10.0 Million Bought-Deal Public Offering of Units

GlobeNewswire June 8, 2021

IIROC Trading Halt - VPH

Canada NewsWire June 8, 2021

Valeo Pharma Provides Update on Private Payer Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler®

PR Newswire June 1, 2021

Valeo Pharma Projecting Record Revenues for Second Quarter 2021

PR Newswire May 26, 2021

Valeo Pharma Joins Innovative Medecines Canada

Canada NewsWire May 17, 2021

Valeo Pharma Announces Voting Results of its 2021 Annual General and Special Meeting of Shareholders

Canada NewsWire April 29, 2021